A Study to Evaluate the Relative Bioavailability and Tolerability of Bimekizumab in Healthy Subjects

Clinical trial NCT05028127 · COMPLETED

Trial details

NCT number: NCT05028127
Sponsor: UCB Celltech
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2016-03-04
Primary completion: 2016-06-17
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.